en · de · es · fr · pt
peptide-index.peptides1004.com › Topic › Background And Receptor Selectivity — 2026 Update

Background And Receptor Selectivity — 2026 Update

By Editorial Desk · published 2025-07-13 · last reviewed 2025-08-08 · Topic

五肽 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2025-08-08 and is reviewed periodically as new material appears.

Background and Receptor Selectivity

Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.

Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.

背景与受体作用机制

现有文献多来自小规模、短期的研究,涉及生长激素缺乏、术后肠麻痹等方向。长期使用是否导致受体脱敏,以及重复给药后效应是否衰减,仍属开放问题。不同研究之间的剂量、给药途径和受试者特征差异较大,因此结论外推需谨慎。关于临床获益的确切证据尚不充分,需要更大规模的对照试验来澄清。

Ipamorelin 是一种合成五肽,在 20 世纪 90 年代被报道为生长激素促分泌剂。其结构基于胃饥饿素受体激动剂的设计思路,但并非天然激素。早期药理学研究显示,它可刺激垂体释放生长激素,而对应激激素轴的影响相对较小。该化合物常被用作研究生长激素调节通路的工具分子。

Ipamorelin at a glance

PropertyValueNotes
Molecular formulaC38H49N9O5Value for the free base
Molar mass711.9 g/molCalculated from the formula
AppearanceWhite to off-white powderTypical lyophilized form
Mechanism classGhrelin receptor agonistAlso described as a secretagogue
Half-lifeAbout 2 hoursReported for human circulation

Handling, Storage and Analytical Verification

Common solvents for laboratory work include water, buffered saline, and dimethyl sulfoxide. Once dissolved, the peptide is exposed to hydrolysis and oxidation, and alkaline conditions accelerate breakdown. Low-binding plasticware and the addition of a carrier protein reduce losses to container surfaces, which can otherwise be substantial at low concentrations. Solutions are typically kept cold and used within days. Investigators working with the compound generally prepare fresh working dilutions rather than storing dilute stocks, and they avoid repeated warming of the same vial.

Reversed-phase high-performance liquid chromatography is the standard method for purity assessment, most often on a C18 column with a water and acetonitrile gradient and trifluoroacetic acid or formic acid as an ion-pairing agent. Mass spectrometry by electrospray or matrix-assisted laser desorption confirms the expected mass and reveals truncated or modified sequences. Amino acid analysis and sequencing provide orthogonal structural evidence. Typical impurities include deletion sequences, oxidized products, and dimeric species. Detection wavelength, usually 214 or 220 nanometers, should be reported because response factors differ between peptides.

Purity is normally reported as a percentage of total peak area, a figure that does not account for water content, residual solvents, or counterions. Trifluoroacetate and acetate are the most frequent counterions in lyophilized peptides, and they shift the true peptide content away from the mass of the powder. A separate quantitative assay is therefore needed to state content accurately. Certificates of analysis often omit these details, which makes batch-to-batch comparison difficult and limits conclusions drawn when results from different suppliers are compared.

Related pages on this site

Background And Receptor Mechanism

Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.

Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.

At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.

Ipamorelin Background and Pharmacology

At the cellular level, ipamorelin binds the growth hormone secretagogue receptor, also called the ghrelin receptor. Activation of this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to release of growth hormone into circulation. Because release follows a pulsatile pattern, studies often report peak concentration and total area under the curve rather than a single time point. Selectivity for this receptor is the property most frequently discussed in comparative work.

Compared with older secretagogues such as hexarelin or GHRP-6, ipamorelin shows weaker stimulation of cortisol, prolactin, and appetite in the animal models used for early characterization. Whether that selectivity is preserved across longer human exposures remains an open question, because published clinical data are limited in size and duration. Reported effects on food intake are generally described as modest. The compound is therefore treated in the literature as a relatively selective research tool rather than a fully characterized therapeutic agent.

Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Researchers at a pharmaceutical company first described it in the 1990s while screening small peptides for growth hormone releasing activity. Its chain contains five amino acid residues, two of which are non-natural building blocks, including 2-aminoisobutyric acid and a naphthylalanine derivative. The molecule was designed to act at the ghrelin receptor while avoiding several effects observed with earlier secretagogues.

Background and Structural Identity

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.

The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.

Background from the literature

== Medical uses == Elagolix is used in the treatment of moderate to severe pain associated with endometriosis in premenopausal women. Endometriosis is a condition in which the endometrium, the inner lining of the uterus, grows outside of the uterus into surrounding tissues and causes symptoms such as pelvic pain and infertility. Around 10% of women may be affected by endometriosis. Elagolix significantly decreases symptoms of dysmenorrhea (menstrual pelvic pain), non-menstrual pelvic pain, and dyspareunia (pain during sexual intercourse) in women with endometriosis. The medication is used at a lower dosage of 150 mg once per day or at a higher dosage of 200 mg twice per day, depending on the severity of symptoms. The effectiveness of elagolix in the treatment of symptoms of endometriosis was demonstrated in the 6-month Elaris Endometriosis I and II (EM-I and EM-II) phase III clinical trials. In Elaris EM-I, the percentage of women who had a clinical response with respect to dysmenorrhea was 46.4% in the lower-dose elagolix group and 75.8% in the higher-dose elagolix group, as compared with 19.6% in the placebo group; in Elaris EM-II, the corresponding percentages were 43.4% and 72.4%, as compared with 22.7% (P < 0.001 for all comparisons).

In humans (and rodents), there are 3 major paired salivary glands and ~600-1000 smaller minor salivary glands. Serous acinar cells are primarily found in the parotid gland and the submandibular gland, while they are almost completely absent in the sublingual gland and most of the minor glands. The parotid gland is the largest of the salivary glands, and possesses acinar cells that are almost exclusively of the serous type. It produces around 50% of human saliva to help with digestion when stimulated, but only about 20% of saliva when resting. Consequently, the saliva it produces is watery and full of the enzyme α-Amylase, which helps break down carbohydrates. The submandibular gland produces the majority (~65%) of saliva in the resting state. It has a mix of serous and mucous acinar cells, and so the saliva it produces is thicker and full of mucus. In the submandibular gland, some acini are predominantly serous acinar cells (serous glands) or predominantly mucous acinar cells (mucous glands), while others are a mix (seromucous glands). The other salivary glands produce the last ~10% of saliva, and mainly possess mucous acinar cells. An exception is the set of Von Ebner glands, minor salivary glands located in the tongue that are primarily serous glands.

PEEK melts at a relatively high temperature (343 °C / 649.4 °F) compared to most other thermoplastics. In the range of its melting temperature it can be processed using injection moulding or extrusion methods. It is technically feasible to process granular PEEK into filament form and 3D printing parts from the filament material using fused deposition modeling – FDM (or fused filament fabrication – FFF) technology. In its solid state PEEK is readily machinable, for example, by CNC milling machines and is commonly used to produce high-quality plastic parts that are thermostable and both electrically and thermally insulating. Filled grades of PEEK can also be CNC machined, but special care must be taken to properly manage stresses in the material. PEEK is a high-performance polymer, but its high price, due to its complex production process, restricts its use to only the most demanding applications.

==== Kidney ==== People with end-stage kidney disease can have chronically elevated cardiac troponin T levels, which are linked to a poorer prognosis. Troponin I is less likely to be falsely elevated.

=== UK relaunch === In 2018, 40 years after the founding of SOLAR Records, the label was relaunched in the UK by the family of the late Dick Griffey, according to issue 77 of UK Publication 'Soul Survivors Magazine' which featured an interview with both Carrie Lucas and new CEO Jessie Tsang. At the helm of the relaunched label is Griffey's widow Carrie Lucas, his daughter Carolyn Griffey and British Chinese music promoter and IP paralegal consultant Jessie Tsang. Solar Records incorporates the Soul Train Records and Soul Train Club brands. Jessie Tsang is CEO with Sonia Damney as Vice President. In 2022 Carrie Lucas, Carolyn Griffey, Dina Andrews, Virgil Roberts participated with US Cable channel TV One for a special episode of the UNSUNG TV series on Dick Griffey and Solar Records. The episode premiered on November 6, 2022.

Sources: en.wikipedia.org

Reference notes

== Habitat and range == C. brunneus are found in Europe, north Africa, and temperate Asia. They prefer dry habitats. They are present in higher numbers in heathland areas compared to agricultural areas. This can be explained by the difference in sward height in the two areas. C. brunneus prefer habitats with sward heights of 100 to 200 mm and fine leaved grass species. In fact a positive correlation between C. brunneus and both Agrostis species and Festuca species exists. Fine leaved grass species and taller sward heights occur more commonly in heathlands where less human alteration of the land occurs compared to agricultural sites. Sward height also influences abundance. A greater number of C. brunneus are found in taller swards although some scientific literature suggests C. brunneus thrives in wastelands. Vertebrate grazing also influences C. brunneus density by directly influencing sward height. Ungrazed areas have higher densities of C. brunneus than grazed areas. Vertebrate grazing is thought to alter plant hormones two of which are known to effect fecundity, abscisic acid, and gibberellins. Additionally grazing results in the production of proteinase inhibitors in plants and the alteration of nitrogen levels. In areas that experience less vertebrate grazing C. brunneus have increased rates of development, higher adult weights, and increased fecundity.

=== Genomic maintenance === Proliferating cell nuclear antigen (PCNA) is a protein involved in DNA synthesis. Under normal physiological conditions PCNA is sumoylated (a similar post-translational modification to ubiquitylation). When DNA is damaged by ultra-violet radiation or chemicals, the SUMO molecule that is attached to a lysine residue is replaced by ubiquitin. Monoubiquitylated PCNA recruits polymerases that can carry out DNA synthesis with damaged DNA; but this is very error-prone, possibly resulting in the synthesis of mutated DNA. Lysine 63-linked polyubiquitylation of PCNA allows it to perform a less error-prone mutation bypass known by the template switching pathway. Ubiquitylation of histone H2AX is involved in DNA damage recognition of DNA double-strand breaks. Lysine 63-linked polyubiquitin chains are formed on H2AX histone by the E2/E3 ligase pair, Ubc13-Mms2/RNF168. This K63 chain appears to recruit RAP80, which contains a UIM, and RAP80 then helps localize BRCA1. This pathway will eventually recruit the necessary proteins for homologous recombination repair.

Bernard Sanders was born on September 8, 1941, in the New York City borough of Brooklyn. His father, Eliasz ben Yehuda Sanders, a Polish-Jewish immigrant, was born in Słopnice, a town in Austrian Galicia that was then part of the Austro-Hungarian Empire and is now in Poland. Elias Sanders immigrated to the United States in 1921 and became a paint salesman. Bernie's mother, Dorothy Sanders (née Glassberg), was born in New York City. Her parents immigrated to the United States from Radzyn, Poland, and Bialystock, Russia. Sanders says he became interested in politics at an early age due to his family background. In the 1940s, many of his relatives in German-occupied Poland were murdered in the Holocaust. Sanders lived in Midwood, Brooklyn. He attended elementary school at P.S. 197, where he won a borough championship on the basketball team. He attended Hebrew school in the afternoons and celebrated his bar mitzvah in 1954. His older brother Larry said that during their childhood, the family never lacked food or clothing, but major purchases, "like curtains or a rug", were not affordable. Sanders attended James Madison High School, where he was captain of the track team and took third place in the New York City indoor one-mile race. In high school, he lost his first election, finishing last of three candidates for the student body presidency with a campaign that focused on aiding Korean War orphans. Despite the loss, he became active in his school's fundraising activities for Korean orphans, including organizing a charity basketball game.

=== Immunity-related === TCTP caused histamine release from the human basophils of a subpopulation of donors, and this release was dependent on IgE. The expression of TCTP is regulated at two distinct levels, depletion of the ER calcium causes an increase in TCTP mRNA abundance, increased cytosolic calcium concentrations regulate gene expression at the post-transcriptional level. Downregulation of the protein levels by siRNA in HTR-8/SVneo (Homo sapiens placenta cells) was associated with a reduced cellular calcium-uptake activity and buffering capacity.

== Life cycle == The eggs hatch 4 to 19 days after the female oviposits. During the larval stage, the mealworms feed on vegetation and dead insects, and molt between each larval stage, or instar (9 to 20 instars). After the final molt, they pupate. The new pupa is whitish and turns brown over time. After 3 to 30 days, depending on environmental conditions such as temperature, it emerges as an adult beetle.

Sources: en.wikipedia.org

Frequently asked questions

Is ipamorelin an approved medicine?

It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.

Which receptor does it target?

It binds the ghrelin receptor, known as the growth hormone secretagogue receptor type 1a. Activation of that receptor triggers signaling that leads to growth hormone release. Selectivity for growth hormone over cortisol and prolactin is the property most often cited for this compound.

What is the reported half-life?

Published estimates place the circulating half-life at roughly two hours in humans. Clearance involves peptidase activity and renal handling. Because the peptide is short-lived, release patterns after administration are usually described as pulsatile rather than sustained.

ipamorelin 是天然存在的肽吗?

不是。它属于人工合成的五肽,设计上模拟胃饥饿素受体的部分作用,但不存在于人体天然激素谱中。

Network